Listen "2025 Pharmaceutical Outlook"
Episode Synopsis
In this episode of RCA Radio®, host Brandon Miller is joined by Anita Michael, Executive Pharma Compliance Expert & Principal Consultant and Rona LeBlanc-Rivera, Director, Regulatory Affairs both at Regulatory Compliance Associates®. We explore possible changes in the Pharmaceutical industry in 2025 and provide you with insight on how to prepare yourself for these upcoming initiatives.Listen in as we go over the expected reduction in the FDA's work force, recently executed guidance documents, regulatory timelines, drug labeling transparency, the broadening scope of OTC products, the use of AI in the regulatory review, and how companies can use 3rd party inspections to help prepare themselves. About RCARegulatory Compliance Associates® (RCA) provides worldwide services to the following industries for resolution of compliance and regulatory challenges:PharmaceuticalBiologic & BiotechnologySterile compoundingMedical deviceWe understand the complexities of running a life science business and possess areas of expertise that include every facet of R&D, operations, regulatory affairs, quality, and manufacturing. We are used to working on the front lines and thriving in the scrutiny of FDA-and globally-regulated companies.As your partners, we can negotiate the potential minefield of regulatory, compliance, quality, and private equity due diligence with insight, hindsight, and the clear advantage of our unique expertise and experience.
More episodes of the podcast RCA Radio
2025 Medical Device Outlook
27/01/2025
New FDA draft guidance for Chemical Analysis
23/10/2024
Global Regulatory Standards
19/12/2023
Technical Program Management
24/02/2023
2023 Industry Outlook - Pharmaceutical
25/01/2023
DHF & Design Control
26/07/2022
What is Irritation and Sensitization?
10/06/2022
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.